Table 3.
≥2 fractures while on AOM (n = 73) |
1 fracture while on AOM (n = 359) |
No fractures while on AOM (n = 5118) |
|
---|---|---|---|
Bisphosphonate (oral) | 64 (88) | 312 (87) | 4213 (82) |
Bisphosphonate (injection or infusion) | 3 (4.1) | 5 (1.4) | 56 (1.1) |
Parathyroid hormone | 0 | 1 (0.3) | 4 (0.1) |
SERM | 4 (5.5) | 34 (9.5) | 602 (12) |
Calcitonin hormone | 1 (1.4) | 3 (0.8) | 48 (0.9) |
Strontium ranelate | 0 | 5 (1.4) | 80 (1.6) |
Steroid hormone | 1 (1.4) | 2 (0.6) | 161 (3.2) |
Bisphosphonates + SERM | 0 | 2 (0.6) | 41 (0.8) |
Bisphosphonates + strontium ranelate | 0 | 1 (0.3) | 0 |
Bisphosphonates + steroid hormone | 0 | 0 | 1 (0.02) |
Bisphosphonates + calcitonin hormone | 0 | 0 | 3 (0.1) |
Calcitonin hormone + strontium ranelate | 0 | 0 | 1 (0.02) |
SERM = selective estrogen receptor modulator.